India, July 1 -- Abivax SA (ABVX) announced the pricing of an upsized and oversubscribed public offering of 6.4 million American Depositary Shares (ADSs) at $125.00 per ADS, raising approximately $800 million (€702 million).
The offering was increased from the previously announced $600 million due to strong investor demand and priced at a 2.39% premium to the three-day volume-weighted average price of its ordinary shares on Euronext Paris.
The financing was led by Leerink Partners, Morgan Stanley, Piper Sandler and Guggenheim Securities as joint bookrunning managers. The offering is expected to close on July 6, 2026, subject to customary conditions. Underwriters have been granted a 15% option to purchase up to an additional 960,000 ...